Israel Englander Obs Eva Sa Transaction History

Millennium Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.34 - $2.08 $160,179 - $248,636	119,537 New	119,537 $192,000
Q2 2021 Aug 16, 2021	SELL	$2.56 - $3.35 $502,458 - $657,514	-196,273 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.01 - $5.05 $322,580 - $810,464	160,488 Added 448.48%	196,273 $638,000
Q4 2020 Feb 16, 2021	SELL	$1.89 - $2.55 $34,422 - $46,443	-18,213 Reduced 33.73%	35,785 $74,000
Q3 2020 Nov 16, 2020	SELL	$2.46 - $6.15 $580,188 - $1.45 Million	-235,849 Reduced 81.37%	53,998 $134,000
Q2 2020 Aug 14, 2020	BUY	$2.01 - $5.95 $539,011 - $1.6 Million	268,165 Added 1236.81%	289,847 $1.71 Million
Q1 2020 May 14, 2020	SELL	$1.87 - $4.47 $61,192 - $146,271	-32,723 Reduced 60.15%	21,682 $52,000
Q4 2019 Feb 14, 2020	BUY	$2.48 - $8.1 $134,924 - $440,680	54,405 New	54,405 $208,000
Q2 2019 Aug 14, 2019	SELL	$10.05 - $14.25 $105,846 - $150,081	-10,532 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$11.82 - $14.48 $85,482 - $104,719	-7,232 Reduced 40.71%	10,532 $135,000
Q4 2018 Feb 14, 2019	SELL	$10.8 - $17.94 $1.25 Million - $2.07 Million	-115,615 Reduced 86.68%	17,764 $225,000
Q3 2018 Nov 14, 2018	SELL	$10.92 - $18.18 $317,182 - $528,056	-29,046 Reduced 17.88%	133,379 $2.41 Million
Q2 2018 Aug 14, 2018	BUY	$10.0 - $17.87 $1.62 Million - $2.9 Million	162,425 New	162,425 $2.46 Million

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.